 |
Prospector
Profile
1116-04
|
| |
| Vyta Corp. |
NAICS |
311119 |
| 370 17th Street, Suite 3640
Denver, CO 80202 |
Description |
Animal Feeds Mfg. |
| (303) 592-1010 |
Employees |
3 |
| http://www.vytacorp.com/ |
Revenue |
(mil) |
0.0000 |
| |
Income |
(mil) |
-4.4600 |
| |
Assets |
(mil) |
0.9270 |
| |
Liability |
(mil) |
0.1080 |
| |
(for the year ended 2007-06-30) |
| |
|
Category:
Audit Concerns
|
| |
|
Event:
GHP Horwath PC raised substantial doubt about the ability of Vyta Corp. to continue as a going concern after auditing its financial statements. The auditor notes that the Company reported a net loss of approximately $4,474,000, substantially all derived from its equity in development stage net losses of its principal investee, a 50% joint venture, whose ability to continue as a going concern is in substantial doubt. The Company has significant cash outflows from operations for the year ended June 30, 2007, and an accumulated deficit of approximately $30,498,000 as of June 30, 2007.
|
| |
|
Intellectual Property:
The Company has developed, and continues to work towards new modifications to, its beta glucan manufacturing process. BioAgra may file for patent protection for its beta glucan products or may keep its processes and procedures as a trade secret. The Company is currently in the process of attempting to license the NCS™ technology to third parties. NCS™ is a method where metallized, hard, microscopic particles are deposited onto one of two contact surfaces, through electrolytic or electro-less plating methods or other methods. The Company currently holds 11 patents with the U.S. Patent and Trademark Office. It also holds several trademarks with the U.S. Patent and Trademark Office. [SEC Filing 10-KSB 10-15-07]
|
| |
|
Description:
The Company engages in the production, marketing, and sale of beta glucan feed additives for the animal feed industry.
|
| |
|
Officers:
Neal Bartoletta (Pres. & CEO); Paul H. Metzinger (EVP, CFO & Sec.)
|
| |
|
Auditor:
GHP Horwath PC
|
| |
|
Securities:
Common Stock-Symbol VYTC.OB; OTC BB;
37,109,845 common shares outstanding as of October 10, 2007.
|
| |
| |
| |
| return to main page |
|
|
